Immune-Related Pathological Features and Predictive Score in Intrahepatic Cholangiocarcinoma Treated With Combined Conversion Immunotherapy
Modern Pathology · 2026
DOI: 10.1016/j.modpat.2026.101020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Wanwan Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Wenzhou Key Lab…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National University Health System, Southeast University, Roche.
Abstract (Originalsprache)
Immune checkpoint inhibitor (ICI)-based combined neoadjuvant/conversion therapy is increasingly used in the management of initially unresectable intrahepatic cholangiocarcinoma (iCCA). Reliable biomarkers in predicting treatment and survival outcome remain underdeveloped. Here, we assessed immune-related pathological features in pretreatment biopsy specimens of initially unresectable iCCA treated with ICI-based conversion therapy. A predictive scoring system (immune therapy predictive score [iTPS]) was developed to predict the patients' oncological outcome. We evaluated 13 immune-related pathological features (tumor-infiltrating lymphocytes, mature tertiary lymphoid structure, lymphoid aggregate, dense plasma cell infiltration, granuloma, neutrophil, foamy macrophage, necrosis, cholesterol cleft, hemosiderin deposition, giant cell formation, neovascularization, and mature fibrosis) in hematoxylin-eosin-stained biopsy specimen slides from 95 iCCA patients. Cox regression analysis was used to evaluate the correlation between these features and recurrence-free survival (RFS) and overall survival (OS). Features showing correlation with survival were selected for iTPS to develop a binary iTPS scheme. Four features (immature fibrosis, tumor-infiltrating lymphocytes, lymphoid aggregate, and hemosiderin) were included in iTPS. A binary iTPS scheme showed patients with low iTPS displaying significantly better RFS (hazard ratio, 1.83; 95% CI, 1.02-3.27; P = .04) and OS (hazard ratio, 12.9; 95% CI, 3.07-54.18; P < .001). In conclusion, we developed an iTPS scheme based on routine hematoxylin-eosin-stained pretreatment biopsy slides. The iTPS can predict the RFS and OS of iCCA patients treated with combined ICI-based conversion therapy. iTPS is a good candidate predictive biomarker in iCCA and provides a new perspective in understanding the tumor immune microenvironment in immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Wenzhou Key Laboratory of Integrated Traditional Chinese and Western Medicine Treatme…
- Zhongda Hospital & Cancer Institute of Xuzhou Central Hospital & Jiangsu Provincial Key Laboratory of Critical Care Medicine & Institute for Advanced Study of Life and Health, School of Medicine, Southeast University, N…
- Department of Pathology, National University Hospital, National University Health System, Singapore.
- Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore.
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
- The 4th Class of Clinical Medicine, 2022 Batch, Second Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Förderung
- National University Health System
- Southeast University
- Roche
- AstraZeneca
- MSD
Zitieren
APA
Chen, W., Sang, Y., Soon, G. S. T., Chew, E. J. C., Wu, G., Lin, X., Luo, R., Gao, Q., Zhou, J., Xia, H., Zhu, K., & Shi, R. (2026). Immune-Related Pathological Features and Predictive Score in Intrahepatic Cholangiocarcinoma Treated With Combined Conversion Immunotherapy. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101020
Vancouver
Chen W, Sang Y, Soon GST, Chew EJC, Wu G, Lin X, et al. Immune-Related Pathological Features and Predictive Score in Intrahepatic Cholangiocarcinoma Treated With Combined Conversion Immunotherapy. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.101020
BibTeX
@article{Chen2026,
author = {Chen, Wanwan and Sang, Yimeng and Soon, Gwyneth Shook Ting and Chew, Edwin Jun Chen and Wu, Gaohua and Lin, Xiyi and Luo, Rongkui and Gao, Qiang and Zhou, Jian and Xia, Hongping and Zhu, Kai and Shi, Ruoyu},
title = {Immune-Related Pathological Features and Predictive Score in Intrahepatic Cholangiocarcinoma Treated With Combined Conversion Immunotherapy},
journal = {Modern Pathology},
year = {2026},
doi = {10.1016/j.modpat.2026.101020}
}
EUVIMED